Atypical ductal breast hyperplasia
Atypical ductal hyperplasia
Atypical glandular cells
Atypical hyperplasia
Atypical lobular hyperplasia
Atypical mole
Atypical squamous cells of undetermined significance
Atypical squamous cells, cannot exclude a high-grade lesion
Atypical teratoid/rhabdoid tumor
Auditory brain stem response test
Auricular acupuncture
Aurora B/C kinase inhibitor GSK1070916A
Aurora kinase inhibitor AT9283

Afatinib dimaleate

Meaning of Afatinib dimaleate:

A drug used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is used in patients whose cancer has certain mutations (changes) in a gene called epidermal growth factor receptor (EGFR).

Afatinib dimaleate is also used to treat squamous cell NSCLC that has spread to other parts of the body and got worse after treatment with anticancer drugs that included platinum. It is also being studied in the treatment of other types of cancer.

Afatinib dimaleate is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Gilotrif. It blocks certain proteins made by the mutated EGFR gene, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow.

ALSO SEE:  Ado-trastuzumab emtansine

Leave a Reply

Your email address will not be published. Required fields are marked *